Lexaria Bioscience Corp (NASDAQ:LEXX) Stock Soars On High Volume: What’s The Buzz?
Lexaria Bioscience Corp (NASDAQ:LEXX) jumped 28% after announcing that its pharmacokinetics and tolerability study VIRAL-A20-3 is complete with encouraging results.
Read more